HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

lexatumumab

an disulfide-linked immunoglobulin G1, immunoglobulin lamda dimer with specificity for the human tumor necrosis factor receptor superfamily, member 10b
Also Known As:
HGS-ETR2; Human Genome Sciences brand of lexatumumab
Networked: 38 relevant articles (1 outcomes, 10 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Humphreys, Robin: 9 articles (01/2013 - 08/2005)
2. Kakehi, Yoshiyuki: 4 articles (04/2012 - 02/2007)
3. Engesæter, Birgit: 3 articles (02/2013 - 01/2012)
4. Flørenes, Vivi Ann: 3 articles (02/2013 - 01/2012)
5. Wu, Xiu-Xian: 3 articles (04/2012 - 12/2007)
6. Zhao, Xiangxuan: 2 articles (01/2015 - 01/2011)
7. Liu, Chen: 2 articles (01/2015 - 01/2011)
8. Humphreys, R: 2 articles (07/2013 - 02/2006)
9. Emilsen, Elisabeth: 2 articles (02/2013 - 04/2012)
10. Dicker, David T: 2 articles (01/2013 - 08/2011)

Related Diseases

1. Neoplasms (Cancer)
2. Kidney Neoplasms (Kidney Cancer)
3. Melanoma (Melanoma, Malignant)
4. Renal Cell Carcinoma (Grawitz Tumor)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. TNF-Related Apoptosis-Inducing Ligand Receptors
2. mapatumumab
3. bortezomib (Velcade)
4. Antibodies
5. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
6. Doxorubicin (Adriamycin)
7. sorafenib (BAY 43-9006)
8. Sirolimus (Rapamycin)
9. Teriparatide (Parathar)
10. Sodium

Related Therapies and Procedures

1. Heterologous Transplantation (Xenotransplantation)
2. Stents
3. Drug-Eluting Stents